4//SEC Filing
ARENA PHARMACEUTICALS INC 4
Accession 0001166279-14-000001
CIK 0001080709operating
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:43 PM ET
Size
8.5 KB
Accession
0001166279-14-000001
Insider Transaction Report
Form 4
BEHAN DOMINIC P
DirectorSVP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2014-01-10$6.00/sh+33,332$199,992→ 516,332 total - Sale
Common Stock
2014-01-10$6.25/sh−33,332$208,325→ 483,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-10−33,332→ 0 totalExercise: $6.00From: 2004-01-18Exp: 2014-01-18→ Common Stock (33,332 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The options were exercisable upon grant, but vested in four equal annual installments beginning on January 18, 2005.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001080709
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 8:43 PM ET
- Size
- 8.5 KB